Neurometrix (NURO)

Neurometrix Stock Analysis & Ratings

NURO Stock Chart & Stats

Day’s Range$4.14 - $4.88
52-Week Range$2.70 - $38.75
Previous Close$5.5
Average Volume (3M)1.93M
Market Cap$30.73M
P/E Ratio-8.1
Next EarningsJul 21, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score3
EPS (TTM)-0.54



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Neurometrix’s price range in the past 12 months?
Neurometrix lowest stock price was $2.70 and its highest was $38.75 in the past 12 months.
    What is Neurometrix’s market cap?
    Neurometrix’s market cap is $30.73M.
      What is Neurometrix’s price target?
      Currently, no data Available
      What do analysts say about Neurometrix?
      Not enough analysts have published a price target to provide an average price target.
      When is Neurometrix’s upcoming earnings report date?
      Neurometrix’s upcoming earnings report date is Jul 21, 2022 which is in 59 days.
        How were Neurometrix’s earnings last quarter?
        Neurometrix released its earnings results on Apr 26, 2022. The company reported -$0.139 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.139.
          Is Neurometrix overvalued?
          According to Wall Street analysts Neurometrix’s price is currently Overvalued.
            Does Neurometrix pay dividends?
            Neurometrix does not currently pay dividends.
            What is Neurometrix’s EPS estimate?
            Neurometrix’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Neurometrix have?
            Neurometrix has 7,130,000 shares outstanding.
              What happened to Neurometrix’s price movement after its last earnings report?
              Neurometrix reported an EPS of -$0.139 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.2%.
                Which hedge fund is a major shareholder of Neurometrix?
                Currently, no hedge funds are holding shares in NURO


                Neurometrix Stock Analysis

                Smart Score
                Price Target
                No data currently available
                The Neurometrix stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description


                NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.

                Similar Stocks
                Price & Change
                Natus Medical
                Sanuwave Health
                Anika Therapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis